[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
for Breast Cancer
Drug: Ribociclib
6 locations incl. Los Angeles
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05870579·Phase 1·Recruiting